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Abstract
Cartilage is a highly differentiated connective tissue that forms mechanical support to 
soft tissues and is important for bone development from fetal period to puberty. It is 
conformed by chondrocytes and extracellular matrix. It is generally believed that adult 
cartilage has no capacity to renewal. A delicate balance between cell proliferation and 
cell death ensures the maintenance of normal tissue morphology and function. Stem cells 
play essential roles in this process. Mesenchymal stem cells (MSCs) can give rise to mul-
tiple lineages including bone, adipose and cartilage. Nestin protein was initially identi-
fied as a marker for neural stem cells, but its expression has also been detected in many 
types of cells, including MSCs. In vivo, chondrocyte turnover has been almost exclusively 
studied in articular cartilage. In this chapter we will review the findings about the chon-
drocyte turnover in lung cartilage. We have presented evidence that there exist nestin-
positive MSCs in healthy adulthood that participates in the turnover of lung cartilage and 
in lung airway epithelium renewal. These findings may improve our knowledge about 
the biology of the cartilage and of the stem cells, and could provide new cell candidates 
for cartilage tissue engineering and for therapy for devastating pulmonary diseases.
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1. Introduction
Cartilage is a connective tissue consisting of cells and extracellular matrix (ECM). These cells are 
called chondrocytes and reside within spaces called lacunae. The ECM is a three-dimensional 
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macromolecular network composed of fibers and ground substance. In the mammals, much 
of the skeleton is first laid down in cartilage, and in the adult body it covers the articular sur-
faces of bones and forms the sole skeletal support of several structures [1].
Normal chondrocytes maintain a functional ECM that replaces itself very slowly and provides 
a shock absorber [2]. However, in mature cartilage, metabolic activity is low, and has been 
thought that adult chondrocytes resist proliferation throughout life. As a result, the mechani-
cal properties of cartilage deteriorate with age [3–5].
Cell death and cell proliferation must be balanced in adult organisms in order to maintain 
homeostasis. Programmed cell death or apoptosis is important in mature organisms for delet-
ing unwanted cells (e.g. aged cells). Most tissues contain stem cells that are able of proliferate 
and differentiate to replace cells that have been lost. A defective cell turnover process may 
have serious consequences to the tissues and the entire organism [6].
The role of chondrocyte turnover in cartilage aging and disease has been poorly analyzed and 
most of the related studies have been carried out in articular cartilage. In this chapter we will 
review the findings about the chondrocyte turnover in lung cartilage.
2. Chondrocyte, cartilage, and pulmonary cartilage
2.1. The chondrocyte
There are two forms of cells in cartilage: chondroblasts and chondrocytes. Chondroblasts are 
actively dividing immature cells which form ECM. They are oval or spindle-shaped cells with 
a spherical nucleus. The cytoplasm is basophilic, rich in ribosomes, rough endoplasmic reticu-
lum, and Golgi saccules [7].
When chondroblasts are completely surrounded by ECM, they are called chondrocytes. They 
reside in spaces within the cartilage matrix known as lacunae. However, the cells fill the lacu-
nae in vivo, as verified by electron microscopic studies. Chondrocytes vary from elongate 
to spherical in shape in relation to their position within the cartilage. They have a spherical 
nucleus with one or more nucleoli. Chondrocyte cytoplasm contains, in addition to glycogen 
and lipid, the usual characteristics of a secretory cell: abundant rough endoplasmic reticulum 
and prominent Golgi complex [8, 9].
The main function of the chondrocyte is to produce, maintain, and remodel the ECM of the 
cartilage. Chondrocytes receive mechanical, electrical, and physicochemical signals transmit-
ted by the ECM and respond by regulating their metabolic activity [3, 9].
2.2. Cartilage
Cartilage is flexible and strong, and is resilient to compression. It forms mechanical support to 
soft tissues and is important for bone development from fetal period to puberty [1, 10].
Cartilage consists of cells (chondroblasts and chondrocytes) and ECM. The ECM is primar-
ily composed of tissue fluid and macromolecules, including collagens, proteoglycans, and 
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glycoproteins. Cartilage is subdivided into three varieties depending on their molecular com-
position: hyaline, elastic, and fibrous [11]. Of these, hyaline cartilage is the most widely dis-
tributed type.
With the exception of the free surfaces of articular cartilages, hyaline cartilage is surrounded 
by a membrane of fibrous connective tissue, the perichondrium. Cartilage is usually devoid 
of blood vessels, so its cells must obtain their oxygen and nutrients by long-range diffusion 
from the perichondrium [12].
2.3. Pulmonary cartilage
The upper respiratory tract includes the nose and nasal passages, paranasal sinuses, the phar-
ynx, and the portion of the larynx above the vocal cords. The lower respiratory tract includes 
the trachea and within the lungs, the bronchi, bronchioles, and alveoli. This system performs or 
participates in several functions: air conduction, gas exchange, olfaction, and phonation [13–15].
Although the air passages take on their mature appearance well before a fetus is viable, they 
undergo significant maturational changes in late gestation. Thereafter, the lungs undergo 
a phase of growth and maturation during the first two decades of live and achieve maxi-
mal lung function approximately at the age of 20 years old for women and 25 years old for 
men. Lung function remains steady from age 20 to 35 years and starts declining thereafter. 
It has been suggested that airway cartilage plays an important role in determining airway 
compressibility and distensibility. Age-related differences in airway mechanical function 
may reflect an increase in stiffness of both airway muscle and cartilage that occurs with 
increasing age [16–18].
Cartilage (hyaline type) has the function of maintaining airway patency and it also serves for 
the attachment of local muscle and connective tissue. It exists in the form of plates of cartilage 
which have characteristics shapes and arrangements at different airway levels [19].
In the trachea and right and left main bronchi, cartilage is present in the anterior and lateral 
walls as C-shaped plates. Approximately 15–20 cartilaginous rings support the trachea. The 
cartilage in the wall of intrapulmonary bronchi is in the form of irregular cartilage plates that 
form a complete but not continuous circumferential support. The smallest bronchi have only 
widely scattered cartilaginous plates in their walls. Terminal and respiratory bronchioles lack 
supporting cartilaginous plates [13, 19].
3. Cell turnover
Physiological cell turnover plays an important role in maintaining normal tissue function 
and morphology. During this process, older differentiated cells are typically eliminated by 
programmed cell death (apoptosis) and replaced by the division progeny of adult stem cells 
(ASC) [20, 21].
A delicate balance among all factors influencing cell turnover is needed to maintain the nor-
mal volume and function of tissues in healthy people. The key points of this homoeostatic 
Chondrocyte Turnover in Lung Cartilage
http://dx.doi.org/10.5772/intechopen.70860
27
process are apoptosis and cell proliferation. Cell turnover is precisely regulated by the inter-
play of various factors, which modulate tissue and cell-specific responses on apoptosis and 
proliferation, either directly, or by altering expression and function of key death and/or cell 
proliferative genes [6, 20, 22].
Age-specific changes in tissue regeneration and repair lead to cell loss and compromise of tis-
sue homeostasis, structure, and function. These phenomena parallel changes in resident stem 
cell function [23, 24].
3.1. Apoptosis
Apoptosis is a process of controlled cellular death whereby the activation of specific death-
signaling pathways leads to deletion of cells from tissue [25]. The term apoptosis was first 
used in a paper by Kerr, Wyllie, and Currie in 1972 to describe a morphologically distinct 
form of cell death [26], discriminating it from necrosis.
Apoptosis plays an essential role in survival of the organisms and is responsible for many 
biological processes such as normal cell turnover, embryonic and brain development, proper 
development and functioning of the immune system, and hormone-dependent atrophy [27, 28].
3.1.1. Apoptosis versus necrosis. Other forms of cell death
Cell death has been broadly classified in two categories: apoptosis and necrosis. Apoptosis 
is a synchronized and energy-requiring process than involves altered expression of key cell 
proliferation and death-inducing genes, and the activation of a group of cysteine proteases 
(caspases) in a complex cascade of events that link the initiating stimuli to the final demise 
of the cell, while necrosis does not involve gene expression and is a passive externally driven 
event resulting from acute cellular injury [20, 29]. However, increasing evidence has been 
accumulating that necrosis can occur in a regulated manner, and that necrosis has a promi-
nent role in multiple physiological and pathological settings [30].
Apoptosis is morphologically characterized by cell shrinkage, detachment from the substrate, 
chromatin condensation, nuclear and DNA fragmentation, cytoplasmic membrane blebbing, 
package of the cell debris into apoptotic bodies, and engulfment by resident phagocytes. 
Necrosis involves increase in cell volume, swelling of organelles, rupture of the plasma mem-
brane, and the subsequent release of the cytoplasmic contents into the surrounding tissue, 
leading to inflammatory reaction [31].
Recently, new forms of cell death have been progressively described, which can be more pre-
cisely distinguished based on molecular pathways. A functional classification of cell death forms 
have been proposed that includes extrinsic apoptosis, caspase-dependent or -independent 
intrinsic apoptosis, regulated necrosis, autophagic cell death, and mitotic catastrophe [30, 31].
3.1.2. Apoptosis mechanisms
Apoptosis can be initiated by exogenous stimuli such as ionizing radiation and chemothera-
peutic drugs, as well as by endogenous stimuli such as the absence of oxygen, nutrients or 
growth/survival factors, the presence of DNA damage, or the action of cytokines [32].
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There are two main apoptotic pathways: the extrinsic or death receptor pathway, which is 
triggered from outside of the cell by death ligands, and the intrinsic or mitochondrial path-
way, which is triggered from inside the cell as a response to various stress signals. Both intrin-
sic as well as extrinsic pathways of apoptosis are associated and influence each other [33]. 
Another pathway of apoptosis as also been recognized that involves T- and NK-cell mediated 
cytotoxicity and perforin-granzyme-dependent killing of the cell [34].
The three pathways converge on the same execution pathway: the activation of cysteine pro-
teases of the caspase family, which selectively digest the cell from within. The perforin/gran-
zyme pathway also activates another cell death pathway via single stranded DNA damage 
[29, 34].
3.1.3. Methods of apoptosis detection
Since the pathways of apoptosis are very complicated, there are a lot of features of it than can 
be evaluated. A great number of methods have been developed to detect apoptosis, such as 
morphological techniques, proteomic and genomic approaches, spectroscopic methods, flow 
cytometry, caspase activity assays, microfluidic applications, and electrochemical methods 
[35]. Each assay has advantages and disadvantages. Understanding the strengths and limita-
tions of the assays would allow investigators to select the best methods for their needs [28, 36]. 
A description of all assays for detecting apoptosis is beyond the scope of this chapter. We will 
briefly describe the assays to detect apoptosis most employed by our group.
3.1.3.1. Light microscopy
Detection of apoptotic cells in hematoxylin and eosin-stained tissue sections with light 
microscopy is possible because of characteristic morphological features of apoptosis. They 
include condensation of the chromatin in granular masses along the nuclear envelope, cell 
shrinkage, convolution of the cellular and nuclear outlines, and fragmentation of the nucleus. 
The apoptotic cell breaks into membrane bound bodies that are quickly removed by neigh-
boring macrophages. The condensed or fragmented nucleus can be detected with DNA dyes 
such as propidium iodide, Hoechst dye, or DAPI (4′,6-diamidino-2-phenylindole). Light 
microscopy detects the later events of apoptosis and confirmation with other methods may 
be necessary [37, 38].
3.1.3.2. Transmission electron microscopy (TEM)
A more definitive method of morphologic identification of apoptotic cells is TEM, because 
apoptosis is confirmed by several of its ultrastructural characteristics. TEM detects chroma-
tin condensation and convulsions in and around the nuclear envelope that precedes nuclear 
fragmentation, the condensation of cytoplasm with the disappearance of the microvilli, blebs 
on the cell surface, and the loss of cell junctions. If immunochemical staining is employed, 
then chemical information can be also obtained. However, there are limitations in TEM as 
an apoptosis detection method, including that apoptotic cells detected by TEM are in the last 
stage of apoptosis, and that much time and a high skill are required for preparation of ultra-
thin sections used in TEM [35, 39].
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3.1.3.3. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)
TUNEL method is based on the assumption that genomic DNA is fragmented in a dying cell, 
producing fragments of consistent length in apoptotic cell death, as opposed to necrotic cell 
death where DNA is believed to be randomly degraded [40, 41]. The method consists of the 
labeling of DNA nick ends by terminal deoxynucleotidyl transferase (TdT) which incorpo-
rates the labeled nucleotide (most often dUTP) in the places of DNA strain breaks. The dUTP 
can then be labeled with a variety of probes to allow detection by light microscopy, fluores-
cence microscopy, or flow cytometry [42].
TUNEL method is suitable for analysis of apoptosis in individual cells applicable to all kinds 
of material: cultured cells, tissues, and blood samples, even if a material contains only a few 
apoptotic cells. Another advantage of the TUNEL staining is that detects cells at a relatively 
early stage of apoptosis [39, 43]. However, this method also has drawbacks. Notably, it has 
been reported that the TUNEL assay also detect necrotic and autolytic cells in addition to 
apoptotic cells [44, 45].
3.2. Cell proliferation
Cell proliferation is the process whereby cells reproduce themselves by growing and then 
dividing into two equal copies [46]. This process is a fundamental requirement for normal 
development and homeostasis.
Cell division consists of two consecutive processes, mainly characterized by DNA replication 
and segregation of replicated chromosomes into two separate cells. The process of replicating 
DNA and dividing a cell can be described as a series of coordinated events that compose a 
cell cycle [47, 48].
3.2.1. The cell cycle
The cell cycle can be subdivided into two stages: interphase and mitosis. Genome replication 
occurs during the interphase, and its segregation to the daughter cells during the mitosis. The 
interphase includes G
1
, S, and G
2
 phases. Cells in G
0
 are not actively cycling and have to be 
stimulated by growth factors in order to enter the cell cycle in G
1
 [49]. Mitosis includes pro-
phase, prometaphase, metaphase, anaphase, and telophase, and also cell division (cytokinesis), 
which overlaps the final stages of mitosis [50, 51]. In this chapter we will further analyze only 
the interphase.
DNA synthesis and doubling of the genome take place during the synthetic or S phase. This is 
preceded by a period or gap of variable duration called G
1
 during which the cell is preparing 
for DNA synthesis, and is followed by a period known as the second gap or G
2
, during which 
the cell prepares for mitosis [48, 52].
3.2.1.1. Cell cycle regulation
Cell proliferation is a process fundamental to development, growth, homeostasis, adapta-
tion to disease, and neoplasia. For this reason, cell cycle events must be tightly regulated 
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to ensure that they occur in the correct order with respect to each other and that they occur 
only once per cell cycle [53].
At least two types of cell cycle regulation mechanisms have been recognized: cell cycle check-
points, which are surveillance mechanisms that monitor the order, integrity, and fidelity of 
the major events of the cell cycle [54], and a cascade of activation and deactivation of a series 
of proteins that relay a cell from one stage to the next [47].
3.2.1.1.1. Cell cycle checkpoints
Cell cycle checkpoints are a series of control systems enabling proliferation only in the pres-
ence of stimulatory signals (e.g. growth factors). They also arrest the cell cycle in response 
to DNA damage in order to provide time for DNA repair. After damage repair, progression 
through the cell cycle resumes. If the damage cannot be repaired, the cell is eliminated by 
apoptosis [55].
The primary checkpoint acts late in G
1
. Once the cell has entered S phase, it is bound to con-
tinue through S, G
2
, and M and thus produce two daughter cells. This checkpoint is some-
times known as the “point of no return” in the cell cycle with respect to S phase entry [56].
Additional checkpoints exist in S phase to activate DNA repair mechanisms when necessary. 
Furthermore, incomplete DNA replication or DNA damage triggers checkpoint pathways 
that block the G
2
/M transition to ensure that cells have completely replicated their DNA and 
that it is intact before they enter mitosis [57].
Finally, the spindle assembly checkpoint acts during mitosis to maintain genome stability 
by delaying cell division (cytokinesis) until accurate chromosome segregation can be guar-
anteed [58].
3.2.1.1.2. Cyclin-dependent kinases (Cdks) regulation
The main families of proteins that play key roles in controlling cell cycle progression are the 
Cdks, the cyclins, the Cdk inhibitors (CKIs), and the tumor-suppressor gene products—the 
retinoblastoma protein (pRb) and p53 [59].
Progression of the cell through the cell cycle is mediated by sequential activation and inactiva-
tion of Cdks. The Cdks are a family of serine/threonine protein kinases that are activated at 
specific points of the cell cycle by the cyclins. Cdks activity can be counteracted by cell cycle 
inhibitory proteins, the CKIs [60, 61].
Activated Cdks induce downstream processes by phosphorylating selected proteins. pRb 
is a downstream target of Cdks-cyclins complexes [62]. Full pRb hyperphosphorylation 
releases pRb from E2F relieving repression of E2F target genes and allowing for activated 
E2F-dependent transcriptional induction and cell cycle progression [63].
p53 is stabilized in response to DNA damage, oncogenic stress, and various other stress 
conditions and activates transcription of a number of genes (including p21, Mdm2, and Bax) 
that induce cell cycle arrest or apoptosis. At the G
1
/S checkpoint (see above), cell cycle arrest 
induced by DNA damage is p53-dependent [64].
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3.2.2. Identification and measurement of cell proliferation
Assessment of cell proliferation is often of relevance in biomedical science, and a range of 
techniques have evolved to identify and quantify the process, generally by recognition and 
calculation of the number of cells in S or M phase [65].
A variety of markers have been used to determine cell cycle status and quantify cell prolifera-
tion, including the identification of mitotic figures, tritiated thymidine incorporation, bromode-
oxyuridine incorporation, expression of proteins such as the proliferative cell nuclear antigen 
(PCNA), Ki-67, cyclins and Cdks, and the analysis of Cdks phosphorylation status [62, 66].
Of importance for this chapter are the immunohistochemical methods that detect prolifera-
tion-associated antigens. Ideally, such methods should be applicable to routinely processed 
tissues, they should be relatively inexpensive and the results easily quantified and interpreted 
[67]. The best known markers employed to recognize proliferating cells are Ki-67 and PCNA.
Cells express Ki-67 during G
1
, S, G
2
, and M phases, but not during the resting phase G
0
. Its 
levels are low in the G
1
 and S phases and rise to their peak level in M. Later in the M phase, 
a sharp decrease in Ki-67 levels occurs [68]. Ki-67 is required to maintain individual mitotic 
chromosomes dispersed in the cytoplasm after their release from the nuclear envelope, 
through a surfactant mechanism [69].
Ki-67 is widely used as a proliferation marker because it provides a rapid and relatively inex-
pensive method of measuring dividing cells [65, 70]. However, the short half-life of Ki-67 
(1–1.5 h, regardless of the cell position in the cell cycle [71, 72]) makes its detection difficult. 
Furthermore, some healthy tissues can express low levels of Ki-67 [68].
PCNA was first shown to act as a cofactor/auxiliary protein for DNA polymerase δ, which is 
required for DNA synthesis during replication. However, besides DNA replication, PCNA 
functions have been associated with other cellular processes such as chromatin remodeling, 
DNA repair, sister-chromatid cohesion, and cell cycle control [73]. During DNA replication, 
presence of PCNA is necessary for synthesis of the leading strand. Levels of PCNA expression 
are therefore highest during S phase, with little to no expression during G
1
 and intermediate 
levels in G
2
 and M phases [62, 74].
PCNA detection has been widely used in immunohistochemical studies of cell proliferation. 
However, some authors claim that PCNA is not a reliable marker of this process because it is 
a pleiotropic protein involved in several aspects of cell control and not only in proliferation 
[66]. On the opposite, other authors affirm that PCNA is the most reliable and versatile of 
all markers used to analyze cell proliferation [75]. In the past, we have successfully used the 
immunohistochemical detection of PCNA in studies of cell turnover in lung [76].
4. Stem cells
4.1. Definition and classification
Stem cells are generally defined as clonogenic cells capable of both self-renewal and mul-
tilineage differentiation [77]. For a cell to be considered a stem cell, it must be capable of 
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asymmetrical cell division, producing an exact multipotent replica cell, and an additional 
progeny cell than can perform a more specialized function [78].
Stem cells are classified according to their origin and developmental status in embryonic 
stem cells (ESC) and adult stem cells. Embryonic stem cells (ESC) can be derived from the 
inner cell mass of a blastocyst during gastrulation. They are totipotent cells giving rise to 
the germ line during development and virtually to all tissues of the organism [78, 79]. Adult 
stem cells (ASC) are tissue-resident stem cells that, based on their differentiation potency, 
can be classified as multipotent, oligopotent, or even unipotent [80]. In their tissue of resi-
dency, ASC function as lineage-committed progenitors to cells capable of more highly spe-
cialized tasks [78]. They are involved in tissue homeostasis and repair after wounding over 
the lifetime [79].
Among the tissues and organs harboring ASC, there are bone marrow, vascular walls, adi-
pose tissues, skeletal muscles, heart, and brain, as well as epithelium of lung, liver, pan-
creas, digestive tract, skin, retina, breast, ovaries, prostate, and testis [81]. The bone marrow 
stem cell niche includes the hematopoietic stem cell population, which provides continuous 
renewal of blood cell lineages and the foundation of the immune system, and the mesen-
chymal stem cell population, responsible for osteogenic, adipogenic, and chondrogenic dif-
ferentiation [82].
4.2. Mesenchymal stem cells (MSCs)
The minimal criteria for defining MSCs include: (a) remain plastic-adherent under standard 
culture conditions; (b) express CD73, CD90, and CD105, and lack expression of CD34, CD45, 
CD14 or CD11b, CD79a or CD19, and HLA-DR surface molecules; and (c) differentiate into 
osteoblasts, adipocytes, and chondrocytes in vitro [83, 84].
Originally isolated from bone marrow, MSCs have being isolated from other sites includ-
ing spleen, thymus, muscle, adipose tissue, endometrium, placenta, umbilical cord, umbili-
cal cord blood, peripheral blood, periosteum, periodontal ligament, dental pulp, synovium, 
synovial fluid, tendons, and cartilage [84, 85]. A perivascular location for MSCs has been sug-
gested, correlating these cells with pericytes. This would explain why MSCs can be virtually 
isolated from all tissues [79, 86].
MSCs have demonstrated significant potential for clinical use due to their convenient isola-
tion, their lack of significant immunogenicity permitting allogenic transplantation, their lack 
of ethical controversy, and their potential to differentiate into tissue-specific cell types [87]. 
MSCs may have therapeutic applications in several clinical disorders including myocardial 
infarction, diabetes, sepsis, hepatic failure, acute renal failure, several kinds of lung disease, 
as well as in spinal cord injuries, and bone and cartilage diseases [88, 89].
4.3. Nestin-positive MSCs
The human nestin protein consists of 1621 amino acids and displays a predicted molecular 
weight of 177.4 kDa. It is a class VI intermediate filament protein. Intermediate filaments 
represent, along with microtubules and actin filaments, one of the main components of cyto-
skeleton in animal cells [90].
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Although nestin was first described as a marker of neural stem cells [91], its expression has 
also been shown in various prenatal and adult cells and tissues. Nestin-expressing cell types 
in embryonic and fetal tissues includes developing skeletal muscle cells, developing cardio-
myocytes, endothelial cells of developing blood vessels, pancreatic epithelial progenitor cells, 
and hepatic oval cells. In adult, nestin expression has been found in, for example, satellite 
cells in dorsal root ganglia, retina, pancreatic stellate and endothelial cells, interstitial cells of 
Cajal, muscularis propria, Sertolli cells, and odontoblasts. Nestin has also been found to be 
expressed in injured tissues and in cancer cells [92].
In most of the studies, nestin has been detected by immunohistochemistry [92]. The principal 
advantage of immunohistochemistry over other techniques is that it enables the observation 
of processes in the context of intact tissue [93].
Normally, nestin becomes up-regulated in tissues during embryogenesis and down-regu-
lated during maturation. During tissue injury in the adult, nestin is expressed in cells with 
progenitor cell properties. Furthermore, observational and interventional studies in animals 
and humans have shown that nestin may be an important marker for MSCs. These cells seem 
to act as a tissue reserve and to participate in tissue repair, regeneration, and growth [94, 95].
5. Cell renewal in lung cartilage
Cartilage grows by two methods: appositional growth and interstitial growth. In the former, 
chondroblasts in the perichondrium are transformed into chondrocytes. Interstitial growth 
result from mitotic division of pre-existing chondrocytes within the matrix. These two mecha-
nisms occur early in life [96].
In the past, it has been believed that healthy adult chondrocytes maintain a stable resting phe-
notype and resist proliferation and differentiation throughout life [5]. Most cell types reach cell 
cycle arrest after a characteristic number of population doublings. The limit for human chondro-
cytes has been estimated at ~35 population doublings [4]. Their decreasing proliferative poten-
tial has been attributed to replicative senescence associated with erosion of telomere length [97].
We analyzed lung specimens from adult mice embedded in paraffin. Apoptosis was analyzed 
by TUNEL assay. PCNA and nestin were examined by immunohistochemistry. Apoptosis 
and PCNA were detected in lung chondrocytes. Serial section analysis demonstrated that 
cells in apoptosis were different from PCNA-positive cells, indicating that turnover was 
occurring. Chondrocytes were negative for nestin. However, nestin-positive cells were found 
in connective tissue associated with cartilage, in some specimens in close proximity of it and 
in perivascular cells. Thus, the findings of this work indicated that cell turnover in adult lung 
cartilage is possible, and that it may be mediated by nestin-positive cells [98].
In another related work, we found nestin-positive cells inside of lung cartilage and cells in 
division very close from them. This finding indicated that there exist nestin-positive MSCs in 
the adult that are able to differentiate into lung chondrocytes, perhaps to maintain homeosta-
sis and/or repair damaged tissue [99].
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For a long time it has been considered that cartilage contains a unique type of cell: the chondro-
cyte. However, nestin-positive MSCs has been found in cultured human adult lung cells, which 
underwent chondrogenic differentiation [100], and evidence from our investigations [98, 99] 
indicates that besides chondrocytes there exist nestin-positive MSCs in the adult lung cartilage.
The nestin-positive MSCs might be circulating in the blood stream or remain located in local 
blood vessels and be able to populate the cartilage when necessary, and/or might reside inside 
it. Other authors have shown that murine MSCs embolised within pulmonary blood vessels 
following systemic injection, and then transmigrated and differentiated into cartilage [101].
Finally, in another work, we found nestin-positive cells in perivascular areas and in connective 
tissue that were in close proximity of the bronchial airway epithelium. Nestin-positive cells 
were also found among the cells lining the airway epithelium, perhaps in order to participate 
in epithelial renewal [102]. Thus, stem cell reported in our works might be a pluripotent cell, 
which are able to generate several types of lung tissues. Other researchers presented evidence 
that a pluripotent stem cell exists in the lung that can generate lung-like tissue in vitro [103, 104].
6. Conclusion
Most of cells, tissues, and organs show continuous turnover. A delicate balance between cell 
proliferation and cell death ensures the maintenance of normal tissue morphology and func-
tion. Stem cells play essential roles in the growth, homeostasis and repair of many tissues. 
MSCs can give rise to multiple lineages including bone, adipose, and cartilage. The interme-
diate filament protein nestin was initially identified as a marker for neural stem cells, but its 
expression has also been detected in many types of cells, including MSCs.
It is generally believed that adult cartilage has no capacity to renewal. Taken together, our 
findings indicate that there exist nestin-positive MSCs in healthy adulthood that participates 
in the turnover of lung cartilage and in lung airway epithelium renewal. These findings may 
improve our knowledge about the biology of the cartilage and of the stem cells, and could 
provide new cell candidates for cartilage tissue engineering and for therapy for devastating 
pulmonary diseases.
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